Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nilemycin, an intercalating agent for deoxyribonucleic acid.

I R Shimi, N M Abdallah, F T Ali

    The International Journal of Biochemistry
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Obesity and related diseases: an epidemiologic study in eastern Sicily.

    Minerva gastroenterologica e dietologica·2006
    Same author

    Biochemical studies on proteins from cheese whey and blood plasma by-products.

    Die Nahrung·1998
    Same author

    Effect of praziquantel on hepatic fibrosis in experimental Schistosomiasis mansoni.

    Experimental and molecular pathology·1988
    Same author

    Isolation, characterization and the mechanism of action of AS-IBBR, polypeptide antibiotic.

    The Journal of the Egyptian Public Health Association·1985
    Same author

    A new antitumour substance, 7-oxabicyclo (2.2.1)-5-heptene-2,3-dicarboxylic anhydride.

    European journal of cancer & clinical oncology·1982
    Same author

    Gluconimycin, an inhibitor for pyrimidine synthesis.

    Indian journal of experimental biology·1982

    Nilemycin (NM) inhibits DNA synthesis and repair in cancer cells. This antibiotic shows potential against Sarcoma 180 tumors by interfering with DNA structure and function.

    Area of Science:

    • Biochemistry
    • Molecular Biology
    • Pharmacology

    Background:

    • Nilemycin (NM) is an antibiotic with potential cytotoxic effects.
    • Understanding NM's mechanism of action is crucial for its therapeutic development.

    Purpose of the Study:

    • To investigate the molecular mechanisms underlying Nilemycin's anti-tumor activity.
    • To determine the specific cellular processes affected by NM.

    Main Methods:

    • Assessing NM's effect on tumor cell lines (Sarcoma 180, Leukemia 1210).
    • Measuring de novo nucleic acid and protein synthesis in Yoshida rat sarcoma cells.
    • Analyzing DNA structure and integrity using ultracentrifugation and UV spectroscopy.
    • Evaluating NM's impact on DNA repair enzymes like polynucleotide ligase.

    Related Experiment Videos

    Main Results:

    • NM inhibited Sarcoma 180 but not Leukemia 1210 cells near toxic doses.
    • NM significantly inhibited de novo RNA synthesis and, to a lesser extent, protein synthesis.
    • NM altered DNA sedimentation coefficients and induced spectral changes, suggesting structural modifications.
    • NM markedly inhibited the repair of nicked DNA by polynucleotide ligase.

    Conclusions:

    • Nilemycin interferes with de novo nucleic acid synthesis and DNA repair.
    • NM's mechanism likely involves intercalation into nicked DNA, hindering ligase activity.
    • These findings suggest NM's potential as an anti-cancer agent targeting DNA integrity.